Related Experiment Video
Updated: Apr 27, 2026

Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production
Published on: June 2, 2023
Variability and predictors of urinary concentrations of phthalate metabolites during early childhood
Deborah J Watkins1, Melissa Eliot, Sheela Sathyanarayana
1Department of Epidemiology, Brown University , Providence, Rhode Island 02912, United States.
Insights
Urinary phthalate metabolite levels in young children vary with age and product use. While some phthalates decreased due to regulations, others increased, highlighting the need to assess replacement chemical safety.
Area of Science:
- Environmental Health
- Pediatric Toxicology
- Exposure Science
Background:
- Phthalate metabolite variability and predictors in preschool children are understudied.
- Temporal trends in phthalate use and restrictions in children's products require assessment.
Purpose of the Study:
- To identify demographic, behavioral, and temporal predictors of urinary phthalate metabolite concentrations in young children.
- To assess changes in phthalate exposure over time in relation to regulations.
Main Methods:
- Prospective birth cohort study with up to five urine samples collected annually from 296 children (ages 1-5).
- Linear mixed models used to assess variability (ICCs) and demographic predictors.
- Multivariable linear regression examined associations between product use and phthalate metabolites at age 5.
Main Results:
- Urinary monoethyl phthalate showed least variation (ICC=0.38), while di-2-ethylhexyl phthalate (ΣDEHP) metabolites showed most (ICC=0.09).
- Fast food consumption linked to butylbenzyl phthalate and di-isononyl phthalate (DiNP) exposure; personal care products linked to diethyl phthalate.
- ΣDEHP metabolite concentrations decreased, while DiNP metabolite concentrations increased over the study period (2004-2011).
Conclusions:
- Phthalate metabolite concentrations change with age, indicating evolving exposure patterns.
- Regulations may reduce DEHP exposure, but increased DiNP suggests a need to evaluate the safety of replacement chemicals.
- Further research is crucial to characterize the nature and toxicity of phthalate alternatives.
Abstract:
The variability and predictors of urinary concentrations of phthalate metabolites in preschool-aged children have not been thoroughly examined. Additionally, the impact of temporal changes in the use and restriction of phthalates in children's products has not been assessed. Our objective was to identify demographic, behavioral, and temporal predictors of urinary phthalate metabolite concentrations in young children. Between 2004 and 2011, we collected up to five urine samples from each of 296 children participating in a prospective birth cohort during annual study visits at ages 1-5 years. We used linear mixed models to calculate intraclass correlation coefficients (ICCs), a measure of within-individual reproducibility, and identify demographic predictors of urinary phthalate metabolites. We used multivariable linear regression to examine cross-sectional relationships between food packaging or personal care product use and phthalate metabolites measured at age 5 years. Across annual measurements, monoethyl phthalate exhibited the least variation (ICC = 0.38), while di-2-ethylhexyl phthalate (ΣDEHP) metabolites exhibited the most variation (ICC = 0.09). Concentrations changed with age, suggesting age-related changes in phthalate exposure and perhaps metabolism. Our findings suggest that fast food consumption may be a source of butylbenzyl phthalate and di-isononyl phthalate (DiNP) exposure, and some personal care products may be sources of diethyl phthalate exposure. Concentrations of ΣDEHP metabolites decreased over the study period; however, concentrations of DiNP metabolites increased. This finding suggests that manufacturer practices and regulations, like the Consumer Product Safety Improvement Act of 2008, may decrease DEHP exposure, but additional work characterizing the nature and toxicity of replacements is critically needed.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacogenetics of Drug Metabolism: Overview
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacokinetics in Pediatric Patients: Drug Excretion

